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Abstract
Concurrent with a rise in opioid abuse during pregnancy is an increase in the number of babies
born with Neonatal Abstinence Syndrome (NAS). Despite this crisis, no single treatment has
been identified for NAS. This paper sought to analyze and synthesize research evaluating the
effectiveness of breastfeeding and rooming-in care on the need and length of pharmacologic
treatment and length of hospital stay for neonates with NAS. Twenty-six peer reviewed research
articles published between 2006 and 2017 were selected from PubMed and CINAHL for
analysis. The studies focused on neonates with NAS born to mothers addicted to opioids or
undergoing opioid maintenance treatment (OMT). The studies reviewed included systematic
reviews and research studies utilizing control and intervention groups in various countries with
sample sizes ranging from 16 to 952 neonates. Findings indicate that breastfeeding and
rooming-in are effective for mild-moderate NAS whereas pharmacologic treatments are
recommended for moderate-severe NAS. In addition to these findings, this paper will discuss
limitations faced while compiling research and the possibility for future research and
implementation into practice.
Keywords: neonatal abstinence syndrome, pregnancy, post-natal care, breastfeeding, roomingin care, length of stay, substance abuse, opioids
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The Effect of Breastfeeding and Rooming-In Care on Neonatal Abstinence Syndrome
Over the last twenty years, there has been a significant rise in the number of pregnant
women who are addicted to drugs, specifically opioids, during their pregnancy. Concurrent with
an escalation in opiate prescription abuse, there has been a five-fold increase in the occurrence of
pregnant women using opiates from 2000 to 2009 (Forray, 2016). As of 2012, a national survey
found that illicit drugs were used by 5.9% of pregnant women in the United States (Forray,
2016). This has resulted in an equally significant rise in the number of neonates born with
Neonatal Abstinence Syndrome (NAS), which is the result of the sudden cessation of fetal
exposure to any substance abused by the mother during pregnancy (Kocherlakota, 2014).
Because opioids mainly affect the central nervous system and gastrointestinal tract, common
signs and symptoms of NAS in neonates include: irritability, increased wakefulness, highpitched crying, repeated yawning and sneezing, exaggerated deep tendon reflexes, increased
muscle tone, tremors, seizures, inadequate feeding and weight gain, uncoordinated continuous
sucking, and temperature instability (Hudak et al., 2012). Between 2009 and 2012, the
occurrence of NAS jumped from 3.4 to 5.8 per 1,000 hospital births in the United States (Patrick,
Davis, Lehman, & Cooper, 2015). Between 2004 and 2013, the incidence of NAS soared from 7
to 27 out of every 1,000 Neonatal Intensive Care Unit (NICU) admissions (Raffaeli et al., 2017).
According to Centers for Disease Control and Prevention (CDC), the rate of NAS increased fivefold from 2000 to 2013 (Barfield, Broussard, Yonkers, & Patrick, 2016). In 2012, the CDC
stated that every 25 minutes a neonate was born with NAS in the United States (Barfield et al.,
2016). There were approximately 21,732 neonates identified with NAS in 2012 in the United
States alone (Patrick et al., 2015).
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Mothers suffering from drug addiction during pregnancy generally live high risk
lifestyles that lead to a variety of social, nutritional, physical, and mental health problems
(Kocherlakota, 2014). Social issues of pregnant addicts include participation in illegal activities,
inability to access appropriate birth control, decreased likelihood of attending prenatal care visits,
and an increased likelihood of smoking and drinking alcohol (Ashraf, Ashraf, Asif, & Basri,
2016). A nutritional issue common to pregnant addicts is malnourishment (Ashraf et al., 2016).
Physical issues that are common among pregnant addicts include irregular menstruation,
amenorrhea, anemia, hypertension, diabetes mellitus, heart disease, increased risk of infection,
and inadequate oral hygiene (Ashraf et al., 2016). Mental health issues among pregnant addicts
include postpartum mood disorders and depression (Pritham, 2013). Due to these issues, women
addicted to opioids during their pregnancy have six times the risk of developing obstetric
complications, including abruptio placenta, premature rupture of membranes, preterm delivery,
preeclampsia, and postpartum hemorrhage (Ashraf et al., 2016). Additionally, maternal drug
addiction puts the neonate at risk for intrauterine growth restriction, congenital anomalies,
cognitive defects, prematurity, low birth weight, respiratory distress syndrome, and NAS (Ashraf
et al., 2016; Raffaeli et al., 2017). These complications of maternal and neonatal lifestyle result
in an increased need for pharmacologic treatment, increased length of hospital stay (LOS), and
increased medical costs (Raffaeli et al., 2017). Due to increased cost of care and increased LOS,
it was estimated that hospital charges for NAS care in 2012 was $1.5 billion (Crook & Brandon,
2017).
With a rise in neonates born with NAS, it is important for nurses to be prepared to use
evidence-based practice to effectively care for neonates born with NAS. The current issue
nurses are facing is that there are heterogeneous standards of care across hospitals globally for
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treating neonates with NAS. According to Kocherlakota (2014), there is no single standard
treatment regimen accepted for NAS due to the complicated and indistinct nature of withdrawal
in neonates and the effects of illicit drugs. Because thorough research has not been performed to
determine the most effective treatment for NAS, nurses are left to treat neonates based on
individual hospital policy rather than on what is best for the neonate. By initiating a standard
plan of care founded on evidence-based practice across hospitals globally, there is potential to
improve patient outcomes and decrease healthcare costs.
In order to establish a foundation for evidence-based practice, it is important to identify
which treatments are currently in practice, including pharmacologic and nonpharmacologic
interventions. Three common pharmacologic interventions used to treat NAS are morphine,
methadone, and buprenorphine. These substances are all opioids, which consist of endogenous
and synthetic drugs that mainly act on opioid receptors in the central nervous system to elicit
analgesia (Hudak et al., 2012). Both morphine and methadone are opioid agonists and
buprenorphine is an opioid mixed agonist-antagonist (Hudak et al., 2012). These opioids have
each been used to treat NAS in neonates, but morphine is currently the preferred treatment
(Kocherlakota, 2014). Neonates who receive pharmacologic treatment have an average LOS of
23 days (Patrick et al., 2015). Two common nonpharmacologic interventions used to treat NAS
are breastfeeding and rooming-in care. Breastfeeding (the feeding of milk produced by the
mother to her neonate) and rooming-in care (the method of tending to both mother and baby in
the same room beginning directly after birth) have both been identified as treatments that
decrease the severity of NAS symptoms in neonates (Abrahams, MacKay-Dunn, Nevmerjitskaia,
MacRae, Payne & Hodgson, 2010; Kocherlakota, 2014).
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The aim of this systematic review is to clarify what is known about the effect of
breastfeeding and rooming-in care on the need for pharmacologic treatment, length of
pharmacologic treatment, and length of hospital stay with neonates suffering from NAS. This
systematic review is guided by the following question: In neonates with NAS, what is the
effectiveness of nonpharmacologic interventions (including breastfeeding and rooming-in care)
instead of or in addition to pharmacologic interventions such as opioid maintenance treatment
(OMT) compared to exclusive OMT on decreasing the need for pharmacologic treatment, length
of pharmacologic treatment, and length of hospital stay?
Methods
The search focused on research studies about neonates with NAS. The mothers described
in these studies were either currently addicted to opioids and other addictive substances or
undergoing OMT. The studies included both pharmacologic and non-pharmacologic
interventions, including morphine maintenance treatment, buprenorphine maintenance treatment,
methadone maintenance treatment, breastfeeding, and/or rooming-in care. The timeline
observed in these studies included the treatment of NAS in neonates from time of birth to
discharge from a healthcare facility. The studies were published in peer reviewed medical
journals published between 2006 and 2017 found through CINAHL and PubMED databases.
When searching the CINAHL and PubMED databases for research studies, the following
keywords were used in a variety of combinations: neonatal abstinence syndrome, breastfeeding,
rooming-in care, drug therapy, opioid maintenance treatment, methadone maintenance treatment,
methadone, buprenorphine, and nonpharmacologic treatment. Seventeen results were found
when the keywords neonatal abstinence syndrome, breastfeeding, and opioid maintenance
treatment were collectively searched on PubMed. Fifty-two results were found when neonatal
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abstinence syndrome, breastfeeding, and drug therapy were collectively searched on PubMed.
Two results were found when neonatal abstinence syndrome, rooming-in care, and opioid
maintenance treatment were collectively searched on PubMed. Eight results were found when
neonatal abstinence syndrome and rooming-in care were collectively searched on PubMed. One
hundred and one results were found when neonatal abstinence syndrome and buprenorphine were
collectively searched on CINAHL. Six results were found when neonatal abstinence syndrome
and rooming-in care were collectively searched on CINAHL.
After each initial keyword search brought back a list of search results, studies from that
results list were first eliminated if the title of the study was irrelevant to the treatment of neonates
with NAS. If the studies were still relevant, their abstracts were examined to determine if the
content of the study was relevant to the treatment of neonates with NAS. If the studies were
irrelevant, they were discarded; if the studies were relevant, their entire contents were thoroughly
read to determine if the studies examined how each NAS treatment affected the outcomes
described in the research question. The outcomes described in the research question include the
need for pharmacologic treatment, length of pharmacologic treatment, and length of hospital stay
for neonates suffering from NAS. If one or all of these outcomes were measured, the study was
included in this systematic review. In total, twenty-six research studies met the criteria
previously stated and were included in this systematic review.
The journals used in this review were selected based on their relevance to the keywords
and if they met the criteria established before conducting the research. The use of the two
databases CINAHL and PubMed ensured a comprehensive review of available studies related to
the topic at hand. This review sought to avoid bias by including studies with multiple points of
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view about the effectiveness of nonpharmacologic and pharmacologic treatments used to treat
NAS.
Results
There were twenty-six research studies included in this systematic review. This section
will provide detailed information on the sample setting, sampling method, sample size, study
design, level of evidence, and specific findings of the research studies included in this systematic
review. The specific findings will describe the conclusions reached regarding the need for
pharmacologic treatment, length of pharmacologic treatment, and length of hospital stay.
Sample Setting
An extensive review of the literature revealed that studies about nonpharmacologic
treatments for neonates with NAS have been conducted across the globe. Included within this
systematic review are two studies from Australia, two from the United Kingdom, six from
Canada, six from the United States, and one from Norway. Considering the worldwide interest
in this neonatal health problem, nurses should seek out research that supports effective evidencebased practices to care for neonates born with NAS.
Two studies were performed at hospitals in Australia, with one study located in
Randwich, New South Wales and one study located in Western Sydney (Abdel-Latif et al., 2006;
Liu, Juarez, Nair, & Nanan, 2015). Two studies were performed at hospitals in the United
Kingdom, with one performed in London and the other in Glasgow (Dryden, Young, Hepburn &
Mactier, 2009; Saiki, Lee, Hannam & Greenough, 2010). One study looked at 18 different
hospitals in Norway (Welle-Strand, Skurtveit, Jansson, Bakstad, Bjarkø & Ravndal, 2013).
Six studies were performed at hospitals in Canada. Three of the six studies were
performed in Vancouver, one of which was specifically performed at the Fir Square Unit of BC
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Women’s Hospital (Abrahams, Kelly, Payne, Thiessen, Mackintosh & Janssen, 2007; Abrahams
et al., 2010; Hodgson & Abrahams, 2012). One of the six studies was performed at hospitals in
Vancouver, Toronto, and Montreal (Ordean, Kahan, Graves, Abrahams & Kim, 2015). Two of
the six studies were specifically performed at Kingston General Hospital in Ontario (McKnight
et al., 2015; Newman et al., 2015).
Five studies were performed at hospitals in the United States. Four of the five studies
were located in the northeastern states, including Pennsylvania, New York, New Hampshire, and
Maine (Brown, Hayes & Thornton, 2015; Holmes et al., 2016; Kraft et al., 2008; Kraft et al.,
2017). The two studies located in Pennsylvania were both conducted at the Thomas Jefferson
University Hospital (Kraft et al., 2008; Kraft et al., 2017). One of the five studies was located in
the Midwest state of Ohio (Isemann, Meinzen-Derr & Akinbi, 2011).
Five studies were systematic reviews that pulled the research necessary for their reviews
from several online databases, including PubMed, Ovid Medline, Embase, CINAHL, Medline,
and Cochrane (Bagley, Wachman, Holland, & Brogly, 2014; Boucher, 2017; Holmes, Schmidlin
& Kurzum, 2017; Kocherlakota, 2014; Pritham, 2013). Four studies were performed at
unspecified hospitals, clinics, or treatment programs (Crook & Brandon, 2017; Hudak et al.,
2012; Jansson et al., 2008; O’Connor, Collett, Alto & O’Brien, 2013). One study was a
compilation of current medical research and expert opinion discussing NAS (Raffaeli et al.,
2017). Given the national and international interest in this topic at prestigious institutions,
synthesis of study results and further research is certainly warranted.
Sampling Method
Among the 26 studies included in this systematic review, a common methodology is
evident with noticeable similarities and differences. The overwhelming majority of studies
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utilized a control group compared with one or more intervention groups. The minority of studies
used databases to synthesize evidence from research studies to draw a conclusion about the
effectiveness of one or more interventions.
Fourteen studies followed two comparison groups during a specific length of time.
However, these 14 studies did not use the same type of comparison groups or conduct research
during the same time periods. Seven of the 14 studies used a comparison group of formula-fed
neonates with a comparison group of breastfed neonates suffering from NAS (Abdel-Latif et al.,
2006; Dryden et al., 2009; Isemann et al., 2011; Jansson et al., 2008; Liu et al., 2015; O’Connor
et al., 2013; Welle-Strand et al., 2013). Three of the 14 studies used a comparison group of
neonates with NAS rooming-in with their mothers and a comparison group of neonates with
NAS admitted to the NICU (Abrahams et al., 2010; Newman et al., 2015; Ordean et al., 2015).
One of the 14 studies specifically used a comparison group with and a control group without
prenatal family education, increased family involvement in symptom monitoring as well as in
nonpharmacologic treatment, and rooming-in care (Holmes et al., 2016). One of the 14 studies
used a comparison group of neonates with NAS who received buprenorphine and a comparison
group of neonates with NAS who received morphine (Kraft et al., 2017). One of the 14 studies
used a comparison group of neonates with NAS who received methadone and a comparison
group of neonates with NAS who received morphine (Brown et al., 2015). One of the 14 studies
used a comparison group of neonates with NAS who received buprenorphine and a comparison
group of neonates with NAS who received neonatal opium solution (NOS) (Kraft et al., 2008).
Three research studies used two comparison groups in which both groups collected data
at different periods of time. These three studies used the same type of control and comparison
groups, but did not conduct the research over the same time periods. The control group consisted
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of a group of neonates suffering from NAS who were admitted to the NICU, while the
comparison group consisted of neonates with NAS that practiced rooming-in with their mothers
(Abrahams et al., 2007; McKnight et al., 2015; Saiki et al., 2010).
One research study looked at one cohort over a specific length of time (Hodgson &
Abrahams, 2012). The cohort was made up of mother-neonate dyads who were cared for
through a rooming-in care program. The medical charts of these dyads were reviewed and data
was collected regarding the type of drug used by the mother, maternal methadone dose at the
time of delivery, and whether or not the neonate required morphine treatment.
One research study used three comparison groups in which each comparison group had
data collected at different periods of time. This study used a comparison group of neonates with
NAS before specific changes in interventions occurred, a comparison group after Baby Friendly
Status (BFS) was implemented, and a comparison group after BFS plus breastfeeding education
was implemented (Crook & Brandon, 2017). Baby Friendly Status in this particular study is
defined as a quality improvement program which promotes breastfeeding through the healthcare
structure and practices (Crook & Brandon, 2017). There are ten steps involved in achieving
BFS, some of these include: allowing mothers and neonates to remain together 24 hours a day,
training the staff how to implement this policy, encouraging breastfeeding on neonate command,
and giving neonates no drinks other than breast milk (Crook & Brandon, 2017).
Five of the studies were systematic reviews. These studies used databases to find
research articles relating to the topic at hand. The keywords used to find the studies for these
five studies included, but were not limited to, LOS, breastfeeding, nonpharmacologic treatment,
rooming in, swaddling, and NAS (Bagley et al., 2014; Boucher, 2017; Holmes et al., 2017;
Kocherlakota, 2014; Pritham, 2013).
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Two of the studies simply compiled current scientific literature on the subject of NAS
(Hudak et al., 2012; Raffaeli et al., 2017). Topics described in these studies included clinical
presentation, diagnostic strategies, and types of nonpharmacologic and pharmacologic therapy.
Most importantly, these studies weighed current evidence to determine when treating NAS with
pharmacologic therapies is necessary. The current work in this area is based on research using
strong methodology. Therefore, the studies provide a good basis for developing policy and
interventions.
Sample Size
Fourteen studies followed two comparison groups during a specific length of time. For
seven of the 14 studies, which used a group of formula-fed neonates and a group of breastfed
neonates, the sample size ranged from 16 to 437 neonates (Abdel-Latif et al., 2006; Dryden et
al., 2009; Isemann et al., 2011; Jansson et al., 2008; Liu et al., 2015; O’Connor et al., 2013;
Welle-Strand et al., 2013). For three of the 14 studies, which used a group of neonates who
roomed-in with their mothers and a group of neonates who were admitted to the NICU, the
sample size ranged from 45 to 952 neonates (Abrahams et al., 2010; Newman et al., 2015;
Ordean et al., 2015). For one of the 14 studies, which used a group with neonates that received
pharmacologic treatment and a group with neonates that received nonpharmacologic treatment,
the total sample size was 163 neonates with 69 receiving pharmacologic treatment and 94
receiving nonpharmacologic treatment (Holmes et al., 2016). For one of the 14 studies, which
used a group of neonates who received buprenorphine and a group of neonates who received
morphine, the total sample size was 63 neonates with 33 receiving buprenorphine and 30
receiving morphine (Kraft et al., 2017). For one of the 14 studies, which used a group of
neonates who received methadone and a group of neonates who received morphine, the total
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sample size was 31 neonates with 15 receiving methadone and 16 receiving morphine (Brown et
al., 2015). For one of the 14 studies, which used a group of neonates who received
buprenorphine and a group of neonates who received neonatal opium solution (NOS), the total
sample size was 26 neonates with 13 receiving buprenorphine and 13 receiving NOS (Kraft et
al., 2008).
Three research studies used two comparison groups in which both groups collected data
at different periods of time. The control group consisted of a group of neonates suffering from
NAS who were admitted to the NICU, while the comparison group consisted of neonates with
NAS that practiced rooming-in with their mothers. The sample size ranged from 44 to 96
neonates (Abrahams et al., 2007; McKnight et al., 2015; Saiki et al., 2010).
One research study looked at one cohort over a specific length of time (Hodgson &
Abrahams, 2012). The cohort was made up of mother-neonate dyads who were cared for
through a rooming-in care program. The total sample size for this study was 295 neonates.
One research study used three comparison groups in which each comparison group had
data collected at different periods of time. This study used a comparison group of neonates with
NAS before specific changes in interventions occurred, a comparison group after Baby Friendly
Status (BFS) was implemented, and a comparison group after BFS plus breastfeeding education
was implemented (Crook & Brandon, 2017). The total sample size of this study was 200
neonates.
Five of the studies used databases to find research articles relating to the topic at hand
(Bagley et al., 2014; Boucher, 2017; Holmes et al., 2017; Kocherlakota, 2014; Pritham, 2013).
The sample size ranged from 5 to 13 articles included within each systematic review. Two of the
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five studies stated that many articles were included within each systematic review, but failed to
state a specific sample size.
Two of the studies simply compiled current scientific literature on the subject of NAS
(Hudak et al., 2012; Raffaeli et al., 2017). The first study cited a total of 165 journal articles
(Hudak et al., 2012). The second study cited a total of 64 journal articles (Raffaeli et al., 2017).
These studies utilized a range of sample sizes to create a strong foundation upon which future
research can be conducted.
Design and Level of Evidence
While conducting a systematic review, it is important that well designed studies are used
in the analyses. Five types of designs were identified after reviewing the studies included in this
review: systematic reviews, randomized controlled trials, controlled trials without randomization,
retrospective cohort studies, and expert opinions. These designs are ranked on predetermined
scales and the strength of the evidence is graded using three areas of expertise: quality, quantity,
and consistency (Schmidt & Brown, 2015).
Systematic reviews are marked as a level one evidence because they combine the results
of studies and statistically determine the effects of the interventions used (Schmidt & Brown,
2015). These types of studies often use both published and unpublished studies (Schmidt &
Brown, 2015). Five of the studies were systematic reviews (Bagley et al., 2014; Boucher, 2017;
Holmes et al., 2017; Kocherlakota et al., 2014; Pritham, 2013).
Randomized controlled trials are marked as a level two evidence. Three of the studies
included in this systematic review were randomized controlled trials (Brown et al., 2015; Kraft et
al., 2008; Kraft et al., 2017). Controlled trials without randomization are marked as a level three
evidence. Four of the studies were controlled trials without randomization (Crook & Brandon,
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2017; Holmes et al., 2016; Jansson et al., 2008; Newman et al., 2015). Both of these types of
trials can be found in nursing literature and help with the promotion of evidence-based practice
(Schmidt & Brown, 2015).
Retrospective cohort studies are marked as a level four evidence. They look at changes
in characteristics of a large sample over time (Schmidt & Brown, 2015). Twelve of the studies
were retrospective cohort studies (Abdel-Latif et al., 2006; Abrahams et al., 2007; Abrahams et
al., 2010; Dryden et al., 2009; Hodgson & Abrahams, 2012; Isemann et al., 2011; Liu et al.,
2015; McKnight et al., 2015; O’Connor et al., 2013; Ordean et al., 2015; Saiki et al., 2010;
Welle-Strand et al., 2013). Expert opinions are marked as a level seven evidence. Two of the
studies were considered expert opinions (Hudak et al., 2012; Raffaeli et al., 2017). Although
these studies range from strongly designed randomized controlled trials to expert opinion, each
study adds to the knowledge amassed in this systematic review and helps researchers better
understand NAS.
Findings
This section will describe the specific findings related to the effectiveness of treatments
for NAS. Both nonpharmacologic and pharmacologic treatments will be discussed, including
breastfeeding, rooming-in care, morphine, methadone, and buprenorphine. Each of these
treatments will be examined to determine how they affect the need for pharmacologic treatment,
length of pharmacologic treatment, and length of hospital stay.
Breastfeeding.
Of the 28 studies examined in this systematic review, similar findings related to
breastfeeding neonates suffering from NAS were identified. A correlation between breastfeeding
and a decrease in the severity of NAS in neonates was found in seven of the studies reviewed
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(Abdel-Latif et al., 2006; Bagley et al., 2014; Dryden et al., 2009; Hudak et al., 2012; Isemann et
al., 2011; O’Connor et al., 2013; Pritham, 2013). Two of these seven studies found that
breastfeeding decreased Finnegan scores, one specifying that the mean score peak decreased
from 9.65 to 8.8 (Bagley et al., 2014; O’Connor et al., 2013). The Finnegan scoring system was
created in 1975 as a neonatal narcotic withdrawal scoring system (Bagley et al., 2014). It
includes 20 items, such as high pitched cries, feeding habits, stools, and is weighted on
pathologic severity (Bagley et al., 2014). The higher the score, the more severe the NAS is
considered.
One study that showed a correlation between breastfeeding and the severity of NAS in
neonates was a systematic review with an objective to provide findings related to the assessment
and management of neonates with NAS (Bagley et al., 2014). A total of 13 studies regarding
nonpharmacologic interventions were included in the review with seven studies specifically
examining the relationship between the neonate feeding method and NAS outcomes (Bagley et
al., 2014). The articles were found on PubMed and Cochrane Databases and were published
between 1975 and 2013 (Bagley et al., 2014). Since the transfer of methadone and
buprenorphine through breastmilk is minimal, breastfeeding is recommended for mothers on
opioid maintenance therapy, but it is not recommended for mothers using illicit drugs (Bagley et
al., 2014). The review shared how breastfeeding is found to act as an analgesic for neonates
(Bagley et al., 2014). Throughout examination of the studies, it was concluded that
predominantly breastfed neonates showed a decrease in Finnegan scores as early as the first nine
days of life when compared to formula fed neonates (Bagley et al., 2014). The average Finnegan
scores in breastfed neonates compared to formula fed neonates was not calculated in this study.
LOS was shown to decrease by up to 19 days in breastfed neonates, and breastfed neonates had a
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30% decreased need for pharmacologic treatment (Bagley et al., 2014). The correlation of
breastfeeding and the decreased need for pharmacologic treatment and LOS will be discussed in
further detail in this section.
Eleven studies found that breastfeeding decreases the neonate’s need for pharmacologic
treatment (Abdel-Latif et al., 2006; Bagley et al., 2014; Dryden et al., 2009; Holmes et al., 2017;
Hudak et al., 2012; Jansson et al., 2008; Kocherlakota, 2014; Liu et al., 2015; O’Connor et al.,
2013; Pritham, 2013; Welle-Strand et al., 2013). The result of one of those studies was not
statistically significant due to a small sample size. Of these 11 studies, seven stated that there
was a decrease in the need for pharmacological treatment in breastfed neonates ranging from
6.9% to 50% compared to formula fed neonates (Abdel-Latif et al., 2006; Bagley et al., 2014;
Dryden et al., 2009; Holmes et al., 2017; Liu et al., 2015; O’Connor et al., 2013; Welle-Strand et
al., 2013).
Three studies found that breastfeeding decreased the length of pharmacologic treatment
in neonates with NAS (Abdel-Latif et al., 2006; Isemann et al., 2011; Welle-Strand et al., 2013).
One of these three studies stated that the length of methadone maintenance therapy in a neonate
would decrease from 15 to 8 days if that neonate was breastfed (Isemann et al., 2011). Another
of the three studies stated that the length of pharmacologic treatment in neonates who were
breastfed was 28.6 days compared to 46.7 days in neonates who were formula fed (Welle-Strand
et al., 2013).
If the need for and length of pharmacologic treatment both decreased, LOS would also
decrease. This finding was shown by eight studies which indicated that breastfeeding reduces
the neonate’s LOS (Abdel-Latif et al., 2006; Bagley et al., 2014; Crook & Brandon, 2017;
Dryden et al., 2009; Holmes et al., 2017; Isemann et al., 2011; Kocherlakota, 2014; Pritham,
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2013). Of these eight studies, five stated that the LOS for breastfed neonates with NAS
compared to formula fed neonates with NAS decreased between 2.3 days and 19 days (AbdelLatif et al., 2006; Bagley et al., 2014; Crook & Brandon, 2017; Holmes et al., 2017; Isemann et
al., 2011).
One study included a quality improvement project to see whether prenatal breastfeeding
initiatives would increase breastfeeding rates and decrease LOS in neonates with NAS (Crook &
Brandon, 2017). The study included three groups: a traditional care group that included births
from February 2014 to August 2014; a baby friendly status (BFS) group that included births
from September 2014 to January 2015; and a BFS plus breastfeeding education group that
included births from February 2015 to July 2015. Hospital achieved BFS means that the facility
provides great care for neonate feeding as well as mother-neonate bonding. LOS was 18.8 days
in the traditional care group, 13.14 days in the BFS group, and 10.41 days in the BFS plus
breastfeeding education group. Breastfeeding initiation rates were higher in women who were
part of group care as opposed to traditional prenatal care. Sixty-seven point three percent of
neonates in the traditional care group needed pharmacologic treatment, 53.9% of neonates in the
BFS group needed pharmacologic treatment, and 34.8% of neonates in the BFS plus
breastfeeding education group needed pharmacologic treatment (Crook & Brandon, 2017).
These results demonstrate that detailed breastfeeding education should be provided to all mothers
with neonates suffering from NAS (Crook & Brandon, 2017).
In opposition to all previous findings, one study stated there is no benefit to breastfeeding
neonates with NAS in regards to NAS scores and the need for pharmacologic treatment (Liu et
al., 2015). The study stated that breastfed neonates were found to have an average NAS score of
1.3 compared to formula fed neonates who had an average NAS score of 1.1 (Liu et al., 2015).
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The study also found that the max dose of morphine required was the same for breastfed
neonates as formula fed neonates, which was 0.5-0.7 milligrams per kilogram per day (Liu et al.,
2015). This study had a small sample size as well as other limitations that could have affected its
results. While it is possible the findings of this study could be supported by future research, this
study alone should not lead to the conclusion that breastfeeding is a poor treatment option for
neonates with NAS.
Overall, these studies indicate that breastfeeding decreases NAS severity, decreases the
need and length of pharmacologic treatment, and decreases LOS. Due to these positive findings,
it was also determined that breastfeeding education should be provided to all mothers with
neonates suffering from NAS.
Rooming-in care.
Out of the 26 studies used in this systematic review, several of the studies provided
findings related to rooming-in care and how it affects neonates with NAS. Seven studies found
that rooming-in care decreases the need for pharmacologic treatment (Abrahams et al., 2007;
Boucher, 2017; Hodgson & Abrahams, 2012; McKnight et al., 2015; Newman et al., 2015;
Ordean et al., 2015; Saiki et al., 2010), with one study specifying that rooming-in care decreases
the need for oral morphine therapy (Abrahams et al., 2007). These seven studies examined how
the need for pharmacologic treatment differed between neonates who roomed-in with their
mothers or were cared for in the NICU. The percentage of neonates who needed pharmacologic
treatment in rooming-in ranged from 11% to 79.2%, whereas the percentage of neonates who
needed pharmacologic treatment who were cared for in the NICU ranged from 45% to 88.7%
(Abrahams et al., 2007; Boucher, 2017; Hodgson & Abrahams, 2012; McKnight et al., 2015;
Newman et al., 2015; Ordean et al., 2015; Saiki et al., 2010). Overall, the percentage of neonates
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who needed pharmacologic treatment was lower by a statistically significant number for those
who roomed-in with their mothers.
Four studies found that rooming-in care decreases the length of pharmacologic treatment
in neonates with NAS (Abrahams et al., 2007; Bagley et al., 2014; Boucher, 2017; Saiki et al.,
2010). These four studies examined the length of pharmacologic treatment in neonates who
roomed-in with their mothers compared to those cared for in the NICU. The length of
pharmacologic treatment for neonates who roomed-in with their mothers ranged from 5.9 to 27
days, whereas the length of pharmacologic treatment for neonates cared for in the NICU ranged
from 18.6 to 32.5 days (Abrahams et al., 2007; Bagley et al., 2014; Boucher, 2017; Saiki et al.,
2010). Overall, the length of pharmacologic treatment was lower by a statistically significant
number for neonates who roomed-in with their mothers.
When the length of pharmacologic treatment decreases for a neonate with NAS, the
length of hospital stay has also been shown to decrease. Seven studies found that rooming-in
care reduces the neonate’s LOS (Abrahams et al., 2007; Bagley et al., 2014; Boucher, 2017;
Holmes et al., 2016; McKnight et al., 2015; Newman et al., 2015; Saiki et al., 2010). Six of the
seven studies compared the LOS in neonates who roomed-in with their mothers and those who
were cared for in the NICU. Between these specific six studies, the mean LOS for neonates who
roomed-in with their mothers was 12.6 days, whereas the mean LOS for neonates cared for in the
NICU was 25 days (Abrahams et al., 2007; Boucher, 2017; Holmes et al., 2016; McKnight et al.,
2015; Newman et al., 2015; Saiki et al., 2010).
In contrast, two studies found that rooming-in care increases the neonate’s LOS
(Abrahams et al., 2010; Ordean et al., 2015). One of these two studies stated that LOS for
neonates who roomed-in with their mothers was 21 days, whereas LOS for neonates who were

THE EFFECT OF BREASTFEEDING AND ROOMING-IN CARE ON NEONATAL

21

cared for in the NICU was 11 days (Abrahams et al., 2010). The other study found that LOS for
neonates who roomed-in with their mothers was 26 days, whereas LOS for neonates who did not
room-in with their mothers was between 14 and 16 days (Ordean et al., 2015).
One specific retrospective cohort study examined rooming-in for neonates with NAS
across three comparison groups (Abrahams et al., 2007). The first group consisted of 32
neonates who roomed-in with their mothers at Vancouver General Hospital during October 2001
and December 2002 (Abrahams et al., 2007). The second group consisted of 28 neonates who
were admitted to a level two nursery at B. C. Women’s Hospital between January 1999 and
September 2001 (Abrahams et al., 2007). The third group consisted of 36 neonates who were
admitted to a level two nursery at Surrey Memorial Hospital between January 1999 and
December 2002 (Abrahams et al., 2007). Results from this study showed that rooming-in care
was associated with decreased need for pharmacologic treatment with morphine, length of
pharmacologic treatment, and LOS. Only 25% of the neonates that roomed-in needed
pharmacologic treatment, whereas between 52.8% and 55.3% of neonates admitted to a level two
nursery needed pharmacologic treatment (Abrahams et al., 2007). The length of pharmacologic
treatment with morphine for neonates who roomed-in with their mothers was 5.9 days compared
to 18.6 days for neonates admitted to a level two nursery (Abrahams et al., 2007). The LOS for
neonates who roomed-in with their mothers was 11.8 days compared to an average of 24.7 days
for neonates admitted to a level two nursery (Abrahams et al., 2007). Besides two outlying
studies that found rooming-in care increased LOS, the majority of studies indicate that roomingin care decreases the need for pharmacologic treatment, decreases the length of pharmacologic
treatment, and decreases LOS.
Pharmacologic treatments.
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Four studies regarding pharmacologic treatments for NAS were included in this
systematic review (Brown et al., 2015; Kraft et al., 2008; Kraft et al., 2017; Raffaeli et al., 2017).
It is crucial to examine the effects of pharmacologic treatments on neonates with NAS because
50-80% of opiate-exposed neonates require some form of pharmacologic treatment (Raffaeli et
al., 2017). For example, the average LOS for neonates with NAS increases from 17 to 23 days
when the neonate has to receive pharmacologic treatment (Raffaeli et al., 2017). Therefore, it is
important to examine each type of pharmacologic treatment in order to know how each of them
affects a neonate’s LOS. These four studies focus on three main pharmacologic treatments:
buprenorphine, methadone, and morphine.
Of the four studies regarding pharmacological, three of them focused on comparing
buprenorphine treatments to other pharmacological agents, such as morphine and methadone
(Kraft et al., 2008; Kraft et al., 2017; Raffaeli et al., 2017). One of the three studies discussed
the nature of the medications themselves, including the pros and cons of buprenorphine,
methadone, and morphine (Raffaeli et al., 2017). The study found that treating neonates with
buprenorphine decreased the need for pharmacologic treatment, decreased the length of
pharmacologic treatment by 40%, and decreased LOS by 24% when compared to treating
neonates with morphine (Raffaeli et al., 2017). The study also found that evidence regarding
how methadone compared to morphine was conflicting and inconclusive (Raffaeli et al., 2017).
Another one of the three studies showed that the length of pharmacologic treatment with
buprenorphine is 13 days shorter than treatment with morphine (Kraft et al., 2017). In addition,
the same study found that the LOS for neonates receiving buprenorphine is 12 days shorter than
for neonates receiving morphine (Kraft et al., 2017). The last of the three studies compared 26
term neonates with NAS who were randomly assigned to receive buprenorphine or neonatal
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opium solution (NOS) (Kraft et al., 2008). The results showed that the mean length of
pharmacologic treatment in the morphine group was 32 days, whereas the mean length of
pharmacologic treatment in the buprenorphine group was 22 days (Kraft et al., 2008).
Additionally, the mean LOS for neonates treated with morphine was 38 days, whereas the mean
LOS for neonates treated with buprenorphine was 27 days (Kraft et al., 2008). Overall, these
findings point to the conclusion that buprenorphine is a more effective pharmacologic treatment
compared to methadone and morphine.
One study compared methadone and morphine pharmacologic treatment in neonates with
NAS (Brown et al., 2015). A total of 31 neonates were randomly selected to receive either
methadone or morphine (Brown et al., 2015). The results showed that the length of
pharmacologic treatment for neonates treated with methadone was 14 days, whereas the length of
pharmacologic treatment for neonates treated with morphine was 21 days (Brown et al., 2015).
Overall, the evidence points towards methadone being a more effective pharmacologic treatment
than morphine. However, more research should be done to compare buprenorphine to
methadone.
Critical Appraisal of the Evidence
The following sections will examine the limitations of findings, the validity and
reliability of the methods and findings, and the limitations across the studies included in this
systematic review.
Limitations of Findings
There are several notable limitations to the findings of this systematic review. Due to the
recent rise in illicit drug use and relative newness of NAS, only a small amount of research has
been performed on NAS in general. As a result, this systematic review was first limited by the
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lack of general research on NAS and further limited by the small number of studies directly
relevant to the aim of this systematic review. Another limitation was only two databases were
searched for relevant studies to include in the systematic review. It is possible that more studies
could have been found if databases in addition to PubMed and CINHAL were searched. The
findings of this systematic review were limited by the keywords chosen to search PubMed and
CINHAL. It is possible that using additional keywords and combinations of keywords that more
studies could have been found. Additionally, the studies selected were free to access by
downloading and reading online PDF versions of the studies. More studies could have
potentially been included if interlibrary loan, paid sources of research, and physical forms of
research were investigated.
Validity and Reliability of the Methods and Findings
Across the studies included in this systematic review, issues have been discovered with
the validity and reliability of the methods and findings. In three studies, the Finnegan scoring
tool was either used incorrectly or subjectively depending on which healthcare professional was
using the scoring tool (Abdel-Latif et al., 2006; Kraft et al., 2008; Newman et al., 2015). In one
study, there were a high number of premature neonates included in the study population, which
could have skewed the reliability of the study (Abdel-Latif et al., 2006). Three studies noted that
not all of the hospitals they gathered data from used the same list of signs and symptoms to
diagnose a neonate with NAS (Abrahams et al., 2010; Newman et al., 2015; Welle-Strand et al.,
2013). Thus, the validity of the methods of these studies is decreased because there could have
been more or less neonates diagnosed with NAS depending on which list of signs and symptoms
were used. Two studies stated they did not know which types of illicit drugs the mothers took
during pregnancy and how those different drugs could have affected the severity of NAS in the
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neonates as a result (Abrahams et al., 2010; McKnight et al., 2015). Therefore, the validity of
the findings of these studies is decreased because it is possible that breastfeeding and rooming-in
were more successful in treating NAS since the illicit drugs the mothers were on had less severe
effects on the neonates. Two studies noted that the validity of their methods was compromised
because there were inconsistencies and/or omissions in their data collection due to
documentation issues in patient charts (Isemann et al., 2011; Ordean et al., 2015). One study
stated their results may not be universally applicable to pregnant women because the
effectiveness of rooming-in may have been affected by whether or not pregnant women received
prenatal care (Ordean et al., 2015). One study stated the validity of their methods may have been
affected because they used a limited number of attending pediatricians to care for their patients
(Holmes et al., 2016). This means that the methods these pediatricians used to care for neonates
with NAS could have negatively affected the outcomes examined in the study. One study noted
the validity of their findings could have been affected because the use of methadone or
buprenorphine maintenance treatments on top of rooming-in care could have masked the true
effects rooming-in care has on neonates with NAS when used on its own (Holmes et al., 2016).
One study stated the reliability of their methods could have been affected because they compared
sample groups of different sizes (Abrahams et al., 2007). The same study noted the reliability of
their findings could have been affected because they were unable to separate out the specific
effects of breastfeeding from the effects of rooming-in care (Abrahams et al., 2007).
Limitations across Studies
Upon reviewing the studies included in this systematic review, several limitations were
found to be issues across the studies. Three major limitations found across the studies included
no randomized group assignment (Abdel-Latif et al., 2006; Abrahams et al., 2007; Boucher,
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2017; McKnight et al., 2015; O’Connor et al., 2013; Ordean et al., 2015; Saiki et al., 2010), no
use of control over the study (Boucher, 2017; Kraft et al., 2008; McKnight et al., 2015;
O’Connor et al., 2013; Ordean et al., 2015), and small study population (Brown et al., 2015;
Crook & Brandon, 2017; Jansson et al., 2008; Kraft et al., 2017; Liu et al., 2015; McKnight et
al., 2015; O’Connor et al., 2013). Other limitations found across the studies include not
accounting for outside variables (Abrahams et al., 2010; O’Connor et al., 2013), not being able to
differentiate between the positive effects of breastfeeding and the effects of skin-to-skin contact
during breastfeeding (O’Connor et al., 2013), not knowing how long mothers breastfed their
neonates with NAS (Bagley et al., 2014; Welle-Strand et al., 2013), only gathering data from one
hospital (Brown et al., 2015; Kraft et al., 2008; Kraft et al., 2017), and not using an ethnically
diverse sample population (Brown et al., 2015). These limitations represent areas where those
conducting the studies failed to ensure the validity and reliability of their study. These areas of
failure should be improved upon with research conducted on NAS in the future.
Recommendations
After an extensive review of twenty-six studies, potential practice and research
implications were determined for future studies that may be conducted. Research findings
support breastfeeding and rooming-in care as effective treatments for mild to moderate cases of
NAS. Results of the studies show that breastfeeding and rooming-in care decrease the need for
pharmacologic treatment, length of pharmacologic treatment, and length of hospital stay. In
moderate to severe cases, it is recommended that nonpharmacologic treatments be used in
combination with pharmacologic treatments. Combining these two treatments will provide the
most effective care in treating NAS symptoms. Three studies showed that methadone is more
effective than morphine as a pharmacologic treatment for NAS, however more research should
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be done to compare buprenorphine to methadone (Kraft et al., 2008; Kraft et al., 2017; Raffaeli
et al., 2017).
As previously noted, an issue facing nurses today is the heterogeneous standards of care
across hospitals globally for treating neonates with NAS. It is recommended that hospitals and
healthcare facilities look further into case studies and the possibility of implementing a standard
treatment protocol for opioid-dependent neonates with NAS derived from evidence-based
practice. Once a standard treatment for NAS is created, it is important to first implement the
standard care locally before advancing to a regional or statewide practice. At a local level, it
would be easier to implement any changes needed to be done to the standard treatment for NAS
before it becomes a regional or statewide practice. In addition, it is recommended that doctors,
nurses, and other healthcare professionals be further educated about the treatment and care of
neonates with NAS. It is important to have well-informed staff members that use evidencebased practice to effectively care for their patients.
Next, it is recommended that research be done to develop a standard screening process
for neonates who are at risk for developing NAS and expecting mothers who have a history or
high risk of substance abuse. Along with this new standard of care and screening process, it is
recommended that the mothers of opioid-dependent neonates be encouraged to take part in an
educational program to teach them the importance of nonpharmacologic practices such as
breastfeeding and rooming-in care and the positive impact they have on their child’s health
outcomes. These educational programs should also teach mothers who still struggle with
substance abuse and addiction how important it is to stop breastfeeding. The transfer of
methadone and buprenorphine through breast milk is minimal. Therefore, breastfeeding is
recommended for mothers on opioid maintenance therapy, but it is not recommended for mothers
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using illicit drugs (Bagley et al., 2014). These educational programs could be offered in local
hospitals as well as in the community. It is recommended that medical treatment, resources, and
teaching are made available for mothers to stop abuse of illicit substances.
Finally, it is recommended that further research be done on treatment for NAS to advance
future practice. Larger, more inclusive studies would be beneficial to determine the trends and
common practices for dealing with cases of NAS. One option would be to conduct more
randomized controlled clinical trials as opposed to retrospective studies in order to obtain a more
accurate comparison of effective treatment plans. Another option would be to conduct a
comprehensive focused review concerning the current standards of care for NAS patients at
various local and state institutions to determine which treatments prove to be most effective for
relieving symptoms of withdrawal with the least negative consequences. This review could
include current as well as previous patient charts and their treatment plans. Further systematic
reviews would also be beneficial to accumulate data that is currently available for both
pharmacologic and nonpharmacologic treatment of NAS. Other systematic reviews could be
more expansive than this systematic review by including data on other pharmacologic and
nonpharmacologic treatments not previously covered. Further studies also need to address longterm morbidity related to neonatal drug withdrawal and whether it is increased or decreased by
pharmacologic treatment. Future studies should also include whether continuing postnatal drug
exposure creates risk of neurobehavioral damage and other morbidities.
Conclusion
Breastfeeding and rooming-in care are effective as stand-alone treatments for most NAS
cases with mild to moderate symptoms. Breastfeeding and rooming-in care should also be used
in congruence with pharmacologic agents to treat moderate to severe symptoms of NAS unless
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otherwise contraindicated. Buprenorphine and methadone have been shown to be more effective
at treating the symptoms of NAS than morphine while further research must be conducted to
compare the effectiveness of buprenorphine to methadone. Further research still needs to be
conducted on the treatment of NAS to determine long-term effects of drug exposure and advance
further practice.
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Systematic Review Table of Evidence (TOE)
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cohort study
Oei, J. (2006). Effects severity of NAS in a
Australia.
Level of
of breast milk on the
population of infants of
Sampling Method:
Evidence: 4
severity and outcome drug-dependent mothers
Reviewed data from all of
of neonatal abstinence who are at risk of NAS.
the infants of drugsyndrome among
Research Question: Is
dependent mothers
infants of drugthere a difference in the
admitted to the Royal
dependent mothers.
severity of NAS and the
Hospital for Women
Pediatrics, 117(6),
need for pharmacologic
between 1998 and 2004.
e1163–e1169. doi:
treatment of NAS in
Sample Size: A total of
10.1542/peds.2005infants of drug-dependent 190 consecutive charts
1561
mothers who consumed
were reviewed for
breast milk as opposed to maternal and neonatal data
formula?
with 105 formula-fed
infants and 85 breast milkfed infants.
2: Abrahams, R. R.,
Kelly, S. A., Payne,
S., Thiessen, P. N.,
Mackintosh, J., &
Janssen, P. A. (2007).
Rooming-in compared
with standard care for
newborns of mothers

Purpose Statement and
Research Question

Purpose Statement: “To
evaluate the effect of
rooming in (rather than
standard nursery care) on
the incidence and severity
of neonatal abstinence
syndrome among opioid
exposed newborns and on

Setting: One group was
from Vancouver General
Hospital (VGH). The first
comparison group was
from B. C. Women’s
Hospital (BCWH). The
second comparison cohort
was from Surrey Memorial

Design:
Retrospective
Cohort Study
Level of
Evidence: 4

Findings /
Conclusion
Infants in the breast
milk group had
lower Finnegan
scores, shorter
LOS, delayed onset
of withdrawal
symptoms, and had
a decreased need
for pharmacologic
treatment than
infants in the
formula group.
Overall, breast milk
intake significantly
reduces the severity
of NAS.

Findings:
Rooming in was
found to be
associated with a
significant
decrease in need
for treatment for
the newborn,

Practice & Research
Implications
Unless there are
medical
contraindications to
breastfeeding, women
of all infants at risk of
NAS should be
encouraged to
breastfeed.

Limitations of
Findings

The Finnegan
scoring system
was used to
monitor
withdrawal from
all types of drugs
although it is only
validated to
evaluate opiate
withdrawal
symptoms. There
could be a threat to
validity due to the
higher number of
premature infants
in the formula
group. There was
no randomized
group assignment.
Practice & Research Limitations of
Implications:
Findings: NonThrough the
random allocation
conclusion, we learned of subjects for
that treatment for NAS study groups
can’t be universally
could be a
one particular
limiting factor in
treatment, due to the
the study design. I
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using methadone or
heroin. Canadian
Family Physician,
53(10), 1722–1730.
http://cfp.ca/content/5
3/10/1722.long

the proportion of mothers
who retain custody of
their babies at hospital
discharge” (p. 1723).
Research Question: Is
there a decrease on the
incidence and severity of
NAS seeing among
opioid exposed newborns
and on the number of
mothers who retain
custody of their babies
with the intervention of
rooming, compared to a
historical cohort and a
concurrent cohort.

Hospital (Surrey).
Sampling Method: The
study used women who
during pregnancy used
heroin or methadone
between October 2001 and
December 2002. The first
comparison group included
a historical cohort of every
third woman who gave
birth between January
1999 and September 2001
who used heroin or
methadone or whose
babies had NAS
symptoms. The second
comparison group included
all women who were under
the same category as
above, between January
1999 and December 2002.
Both comparison groups,
had babies separated from
their mothers during the
first week of life.
Sample Size: A total of 96
women were in the study,
32 from VGH, 28 from
BCWH, and a 36 from
Surrey. .
3: Abrahams, R. R.,
Purpose Statement: To Setting: Fir Square unit of
MacKay-Dunn, M. H., determine if an
BC Women’s Hospital,
Nevmerjitskaia, V.,
interdisciplinary rooming- Royal Columbian, Victoria
MacRae, G. S., Payne, in model of care affects
General, Surrey Memorial,
S. P., & Hodgson, Z.
clinical and psychosocial Matsqui-Sumas-

Design:
Retrospective
cohort study
Level of
Evidence: 4
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shorter hospital
stay, and more
likely to be
discharged in their
mother’s custody.
Lifestyle related
factors
significantly
impacted the
outcomes of the
study.
When the study
restricted their
analysis to nonbreastfeeding
women,
significantly fewer
of the rooming in
newborns required
admission to a
level 2 or 3
nursery. It was
stated that
breastfeeding in
this population
might be delayed
onset of NAS.

impact of lifestyle
related factors. The
article states, “These
results should
encourage further
study in the context of
a randomized design
with prognostic
stratification on
breastfeeding” (p.
1730). Along with
this, under care of
nursing and medical
staff, rooming in
should be
implemented more for
a safe intervention for
NAS.

The rooming-in
group had a
significant decrease
in admission and
length of stay in the

Rooming-in is valuable
to the care of
substance-exposed
infants. Future areas of
study include

also noticed the
sample sizes for
the different
groups were not
the same, which
could have
possibly skewed
the results. The
study could not
separate the
effects of rooming
in from those of
breastfeeding, so
they should
replicate the study
in a large sample
of women not
breastfeeding to
explore outcomes
independently
linked with
rooming in. .

The study could
not report how
morphine
administration
changed neonatal

THE EFFECT OF BREASTFEEDING AND ROOMING-IN CARE ON NEONATAL

G. (2010). An
evaluation of
rooming-in among
substance-exposed
newborns in british
columbia. Journal of
Obstetrics and
Gynaecology Canada,
32(9), 866–871. doi:
10.1016/S17012163(16)34659-X

outcomes in substanceexposed newborns.
Research Question: Is
there a difference in
clinical and psychosocial
outcomes between
substance-exposed
newborns whose care
follows a traditional
standard care model as
compared to an
interdisciplinary roomingin model of care?

4: Bagley, S. M.,
Wachman, E. M.,
Holland, E., & Brogly,
S. B. (2014). Review

Purpose Statement:
“The objective of this
review is to summarize
available

Abbotsford General,
Burnaby General, St.
Paul’s, Richmond General,
Lion’s Gate, Royal Inland,
Kelowna General,
Nanaimo Regional
General, and Prince
George Regional.
Sampling Method:
Reviewed data from all
neonates of women who
used substances during
pregnancy that delivered in
British Columbia between
October 1, 2003 and
December 31, 2006.
Neonates and their mothers
were put into two groups
based on whether they
gave birth at BC Women’s
Hospital (where roomingin care was received) or
elsewhere in British
Columbia (where standard
care was received).
Sample Size: There were a
total of 952 substanceexposed neonates with 355
in the rooming-in group
and 597 in the standard
care group.
Setting: Articles that were
used in this systematic
search were found on
PubMed and the Cochrane

Design:
Systematic
Review
Level of

37

NICU, an increased
chance of receiving
breast milk during
their hospital stay,
and an increased
chance of being
discharged home
with their mothers.
The standard care
group was found to
have a significantly
shorter length of
stay on average (11
days compared to
21 days in the
rooming-in
group).There was
no significant
difference between
the two groups with
respect to neonatal
withdrawal
symptoms.

performing an
economic evaluation
for providing
appropriate care to
substance-using
women and examining
whether rooming-in
influences morphine
administration for
neonatal withdrawal.

outcomes because
this variable
wasn’t recorded.
The presence or
absence of
neonatal
withdrawal
symptoms is
considered
unreliable because
institutions vary
on their reporting
method. The study
was unable to
report which types
of substances were
used during
pregnancy, which
could affect the
comparability of
the two groups.

Findings: Four of
the studies showed
length of hospital
stay three to

Practice & Research
Implications:
This systematic review
clearly showed through

Limitations of
Findings: Studies
often didn’t
differentiate
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of the assessment and
management of
neonatal abstinence
syndrome. Addiction
Science & Clinical
Practice, 9(19), 1-10.
doi: 10.1186/19400640-9-19

evidence on the
assessment and
management of infants
exposed to opioids in
utero, including
assessment
tools used for NAS
scoring,
nonpharmacologic
interventions,
and pharmacologic
management of NAS” (p.
2).
Research Question:
What does published
English-language
literature have to say
about assessment of NAS,
as well as
nonpharmacologic
interventions and
pharmacologic treatments
for NAS?

Database. The articles
were published between
1975 and November 15,
2013.
Sampling Method:
Finding articles using
specific keywords. For
nonpharmacologic
treatment, they included
studies composed of
cohort, case series, case
control, and randomized
controlled trials.
Sample Size: 13 of the
879 articles pertaining to
nonpharmacologic
interventions were
included in this review.

Evidence: 1

5: Boucher, A. (2017).
Nonopioid
management of
neonatal abstinence

Purpose Statement: To
examine the effectiveness
of rooming-in care and
acupuncture as

Setting: PubMed, Ovid
Medline, Embase, and
CINAHL
Sampling Method: The

Design:
Systematic
Review
Level of
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nineteen days
shorter in breastfed
infants. Four of the
studies showed 30
percent decrease in
pharmacologic
treatment for NAS.
One study found
breastfed infants
showed signs of
withdrawal
significantly later
than formula fed
infants.
In regards to
rooming in, two
studies showed
overall decreased
length of hospital
stay and duration
of therapy.
These
interventions
increase bonding
and help normalize
the postpartum
process for women
with opioid history
who may feel
vulnerable and
stigmatized.
Several studies
concluded that
infants with NAS
who receive

multiple articles that
breastfeeding and
rooming in help
neonates with NAS.
Due to these findings,
it is crucial for
hospitals to all start
implementing these
interventions by
teaching their staff on
how to implement
them. The article stated
that low breastfeeding
rates in this population
are likely due to
feeding difficulties in
these infants. This may
open up a window for
learning how to help
these neonates with
feeding difficulties.
Further studies should
also focus on how to
increase rates of
rooming in and
breastfeeding.

between
expressed breast
milk and
breastfeeding,
they did not
compare
exclusive
breastfeeding
versus
combination
feeding and
neonates fed with
formula only.
Duration of
breastfeeding was
also not defined.
Bias was also
introduced due to
the fact that
criteria for
permitting
breastfeeding
were not
described in every
study.

Randomized controlled This study is
trials should be
nonrandomized
performed in the future and uncontrolled.
in order to determine
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syndrome. Advances
in Neonatal Care,
17(2), 84–90. doi:
10.1097/ANC.000000
0000000371

6: Brown, M. S.,
Hayes, M. J., &
Thornton, L. M.
(2015). Methadone
versus morphine for
treatment of neonatal
abstinence syndrome:
a prospective
randomized clinical
trial. Journal of
Perinatology, 35(4),
278–283.
https://doi.org/10.1038
/jp.2014.194

nonpharmacologic
treatments to decrease the
amount of postpartum
neonatal opioid exposure
and length of hospital
stay.
Research Question: Is
there a difference in
amount of postpartum
neonatal opioid exposure
and length of hospital
stay in neonates who
receive rooming-in care
and acupuncture?
Purpose Statement: To
compare the length of
methadone and morphine
treatment for Neonatal
Abstinence Syndrome.
Research Question: Is
there a difference in the
length of treatment for
Neonatal Abstinence
Syndrome between
methadone and
morphine?

above databases were
Evidence: 1
searched for primary
sources on rooming-in care
and acupuncture as
treatments for NAS
Sample Size: Eight
research studies were
chosen to be examined in
this systematic review.

Setting: The Neonatal
Intensive Care and
Pediatric Inpatient units at
Eastern Maine Medical
Center.
Sampling Method:
Mothers in labor who were
admitted between January
2011 and October 2012
were included in the study
if they met the following
criteria: “(i) prenatal
exposure to prescribed
methadone
or buprenorphine, (ii)
meeting our NAS
treatment criteria, (iii)
adjusted gestational age of
> 350/7 weeks assessed
from best menstrual,
obstetrical and physical

Design:
Randomized
Controlled
Trial
Level of
Evidence: 2
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rooming-in care
have a decreased
likelihood of
needing
pharmacologic
treatment; even
when
pharmacologic
treatment is needed,
length of hospital
stay and opioid
exposure is
decreased.

the necessary
components of a
rooming-in care model
for NAS treatment. In
the present, healthcare
providers should be
encouraged to offer
rooming-in care to
postpartum mothers
with infants at risk for
NAS.

Findings: Length
of treatment was
significantly
reduced for
neonates treated
with methadone
(14 days)
compared to
neonates treated
with morphine (21
days). Neonates
treated with
methadone had a
reduced need for a
rescue drug
compared to
neonates treated
with morphine;
however, this
finding wasn’t
statistically

Practice & Research
Implications: A
multicenter trial
should be performed
to enable the findings
of the study to be
generalized to the
neonate population.

Limitations of
Findings: This
study was a single
site pilot and was
unable to include
as many neonates
in the study as
previously hoped.
The small sample
size means that
findings cannot be
generalized to the
population.
Findings could
have been
affected by the
fact that maternal
methadone doses
at birth were
lower in the
neonates treated
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exam criteria, and (iv)
otherwise medically stable
in the opinion of the
attending neonatologist”
(p. 279). Mothers and their
infants who qualified were
then randomly assigned to
receive treatment with
either morphine or
methadone.
Sample Size: 198 motherinfants pairs were screened
for inclusion in the study.
Only 31 neonates met the
inclusion criteria.
7: Crook, K., &
Purpose Statement: “To Setting: An outpatient OB
Brandon, D. (2017).
increase breastfeeding
clinic.
Prenatal breastfeeding rates and decrease
Sampling Method: Infants
education: Impact on hospital length of stay for in the study were divided
infants with neonatal
infants with NAS through into three groups; baseline
abstinence syndrome. prenatal breastfeeding
status was births from
Lippincott Williams & initiatives” (p. 299).
February 2014 to August
Wilkins, 14(4), 299Research Question:
2014, baby friendly status
305. doi:
Would prenatal
(BFS) was births from
10.1097/ANC.000000 breastfeeding initiatives
September 2014 to January
0000000392
for mothers with infants
2015, then BFS plus
suffering from NAS
breastfeeding education
increase breastfeeding
initiative were births from
rates and decrease length? February 2015 to July
2015.
Sample Size: A total of
200 infants were included
in the study.
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significant.

Design:
Controlled
Trials without
Randomizatio
n
Level of
Evidence: 3

Findings: Average
LOS for infants
decreased from
18.8 days in the
baseline group, to
13.1 days in the
BFS group, to 10.4
days in the BFS
with additional
breastfeeding
education group.
Additionally,
infants who
received more than
50 percent human
milk predicted to
have a LOS that
was 2.78 days
shorter than infants
who received all

with methadone.
Additionally, the
sample population
was mostly
European
American and
therefore not
ethnically diverse.

Practice & Research
Implications: Due to
results suggest that
prenatal education
may contribute to an
increase in infants
with NAS receiving
breast milk, which
results in a decrease in
hospital length of stay,
prenatal education
needs to be more
stressed about in the
community.

Limitations of
Findings: The
small sample
cannot make it
possible to infer
direct impact of
the intervention.
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8: Dryden, C., Young,
D., Hepburn, M. and
Mactier, H. (2009).
Maternal methadone
use in pregnancy:
Factors associated
with the development
of neonatal abstinence
syndrome and
implications for health
care resources. British
Journal of Obstetrics
& Gynaecology, 116,
665–671.
doi:10.1111/j.14710528.2008.02073.x

Purpose Statement:
“To investigate factors
associated with the
development of NAS and
to assess the implications
for health care resources
of infants born to drug
misusing women” (p.
665).
Research Question: Is
the implications provided
by healthcare resources
helping infants born to
drug misusing women?

Setting: An inner city
maternity hospital,
Princess Royal Maternity
in Glasgow, United
Kingdom.
Sampling Method: The
article presents data over a
3 year period, from
January 2004 to December
2006 to a large cohort of
drug misusing mothers.
Sample Size: This article
collected data for 437
infants and 440 mothers.

Design:
Retrospective
Cohort Study
Level of
Evidence: 4

9: Hodgson, Z. G., &
Abrahams, R. R.
(2012). A Rooming-in
Program to Mitigate
the Need to Treat for
Opiate Withdrawal in
the Newborn. Journal
of Obstetrics and

Purpose Statement:
“...to explore the effect of
our rooming-in protocol
on the need to treat
withdrawal in the opiateexposed newborn” (p.
475).
Research Question:

Setting: Fir Square, a
Design:
combined care unit within Retrospective
BC Women’s Hospital,
cohort study
mother-child dyads
Level of
between 10/01/2003Evidence: 4
12/31/2006.
Sample Method: Mothers
selected during a certain
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formula.
Findings:
Breastfeeding for
greater than or
equal to 72 hours
was associated
with decreasing the
odds of the neonate
needing treatment
for NAS by 50
percent, which
decreases their
hospital stay. The
article states
breastfeeding
soothes agitated
infants, and the
drugs taken by the
mom are excreted
in the milk,
decreasing the
effects of
withdrawal.
Postnatal stay was
recommended for
intensive parenting
support.
Findings:
“...significant
positive
relationship
between maternal
methadone dose at
delivery, ‘other
opiate’ use, and

Practice & Research
Implications:
Learning preterm
infants have a hard
time suckling, and
many drug misusing
mothers choose not to
breastfeed due to
social prejudice, we
need to increase
programs to help these
causes. The public
needs to learn the
importance of this
intervention. We need
appropriate support
services in the
community as well,
because 50 percent
neonates failed to
attend outpatient
appointments.

Limitations of
Findings: The
article could have
compared health
care resources
now provided for
NAS, compared
to those provided
in the past, to
have a
comparison
group.

Practice & Research
Implications:
Rooming-in is a safer
and more beneficial
alternative to the
current standard
practice of separating
mother and opioid-

Limitations of
Findings:
Recommends
looking into illicit
drug use and
methadone
relationship over
the course of the
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Gynaecology Canada,
34(5), 475–481.
doi:10.1016/S17012163(16)35245-8

Does this rooming-in
program help reduce the
amount of maternal
methadone required to
treat opiate withdrawal in
newborns?

study period.
Sample Size: 295 women
between the age of 27.5 +/6.2 years, 295 neonates.

10: Holmes, A.,
Atwood, E., Whalen,
B., Beliveau, J., Jarvis,
D., Matulis, J.,
Ralston, S. (2016).
Rooming-in to treat
neonatal abstinence
syndrome: Improved
family-centered care
at lower cost.
American Academy of
Pediatrics, 137(6), e1e9.
doi:10.1542/peds.2015
-2929

Purpose Statement:
“To determine how to
improve the care of
opioid-exposed newborns
by involving families,
standardizing assessment
and treatment, and
transitioning to roomingin for the full hospital
stay” (p. e2).
Research Question: Is
there a difference in
length of stay and
hospital costs when a
coordinated program for
NAS is implemented,
which includes
standardized scoring,
weaning of medications,,
and a calm rooming in
environment, compared to
infants treated without

Setting: DartmouthHitchcock, a Children’s
Hospital, which provides
inpatient, critical care, and
pediatric specialty services
to most of New Hampshire
and a portion of Vermont.
Sampling Method: The
research included all birth
hospitalizations between
March 2012 and February
2015, using patients with
reported or laboratory
confirmed maternal opioid
use.
Sample Size: Began with a
pilot group of 10 opioid
dependent women, then
expanded it for all infants.
163 newborns treated for
NAS was used in the
study. 69 newborns

Design:
Controlled
Trials without
Randomizatio
n
Level of
Evidence: 3
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breastfeeding and
the need to treat
the neonate for
withdrawal...mater
nal methadone
dose at
delivery...related to
the duration of
pharmacological
treatment of the
neonate” (p. 475).

dependent infant. “The pregnancy to treat
current study suggests infant opioid
a useful role for
withdrawal.
rooming-in in
mitigating the
relationship between
maternal methadone
dose and the need to
treat the newborn for
opiate withdrawal” (p.
480).

Findings:
For infants with
NAS treated with
the new
implementations,
LOS was reduced
from 23 days to 12
days, system costs
decreased by more
than half. Costs are
decreased not only
because the LOS is
decreased, but due
to the rooming in
model. Critical
care beds no longer
have to be used for
this condition,
which greatly
decreases care
costs.

Practice & Research
Implications: While
achieving the
outcomes they have
hoped for, they also
saw positive family
engagement, increased
family preparation and
involvement, and
trained clinical teams
better on how to take
care of these patient
situations. These
outcomes are major
findings in the nursing
realm, and shows that
involving families,
standardizing
assessment and
treatment, and
rooming in for a full
hospital stay should be

Limitations of
Findings:
The same six
pediatricians were
attending to the
patients. Mother’s
in the hospital
service area are
maintained on
buprenorphine
more commonly
than methadone,
which is seen
with a shorter
length of
treatment.
Rooming-in
program socially
acceptable in
Hampshire and
Vermont because
they do not
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received pharmacologic
treatment, while 94
newborns did not require
pharmacological treatment
and just focused on the
interventions of the study.
These included standardize
scoring, rooming in,
prenatal family education,
and environmental
management.
11: Holmes, A. P.,
Purpose Statement: To Setting: Retrieved from
Schmidlin, H. N., &
identify different benefits databases.
Kurzum, E. N. (2017). of breastfeeding infants
Sample Method: Multiple
Breastfeeding
with NAS to reduce
studies where some infants
considerations for
withdrawal syndromes
are breastfed and some are
mothers of infants
and determine the
formula fed. Each article
with neonatal
clinician's role in
has its own requirements to
abstinence syndrome. promoting, identifying,
determine which infants
Pharmacotherapy:
and counseling the
were formula fed and
The Journal of Human mothers.
which were breastfed.
Pharmacology and
Research Question:
Sample Size: Reviewed
Drug Therapy, 37(7), What role does the
five studies with a focus on
861–869.
clinician have in
breastfeeding compared to
doi:10.1002/phar.1944 advocating for mothers to formula feeding.
breastfeed the infants
born with NAS?
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this program being
implemented?

Design:
Systematic
review
Level of
Evidence: 1

Findings:
Breastfeeding
promotes weight
gain, skin-to-skin
contact, and the
mother-infant
bond. “…infants
with NAS who
were fed primarily
breast milk
compared with
those fed formula
had a later onset of
NAS (10 vs 3 days,
p<0.001), required
pharmacologic
treatment less often
(52.9% vs 79%,
p<0.001), and had
a shorter length of
stay (LOS) (15 vs
19 days, p=0.049)”
(p. 862).

seen in more hospitals
in the future.

impose
mandatory foster
care placement
for opioid
exposed
newborns, unlike
other states.

Practice & Research
Implications:
“Clinicians can play
an important role in
identifying,
promoting, and
counseling mothers of
infants with NAS
regarding
breastfeeding” (p.
868). Monitor for
rebound NAS and
mothers continuing to
abuse substances.

Limitations of
Findings:
Barriers to study
include
inconsistent and
inaccurate data
that causes
healthcare
providers to
continue to
discourage drugdependent
mothers from
breastfeeding.
Social prejudice
against the
mothers is also
another barrier to
treatment.
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12: Hudak, M. L.,
Tan, R. C., Drugs, T.
C. O., & Newborn, T.
C. on F. A. (2012).
Neonatal drug
withdrawal.
Pediatrics, 129(2),
e540–e560.
doi:10.1542/peds.2011
-3212

Purpose Statement:
To explore “therapeutic
options for treatment of
withdrawal” and
determine evidence-based
management practices of
the infant with NAS (p.
1).
Research Question:
What are the current
evidence-based practices
for treatment and
management of NAS?

Setting: Multiple hospitals
and healthcare clinics
Sample Method:
Reviewing scientific
research on the subject of
NAS
Sample Size: N/A

Design:
Expert Opinion
Level of
Evidence: 7
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Findings: “Drug
therapy is indicated
to relieve moderate
to severe signs of
NAS and to
prevent
complications such
as fever, weight
loss, and seizures if
an infant does not
respond to a
committed
program of
nonpharmacologic
support” (p. e548).
“When possible,
and if not
otherwise
contraindicated,
mothers who
adhere to a
supervised drug
treatment program
should be
encouraged to
breastfeed so long
as the infant
continues to gain
weight.
Breastfeeding or
the feeding of
human milk has
been associated
with less severe
NAS that presents

Practice & Research
Implications: Each
clinic should establish
a threshold level for
total opioid exposure,
have weaning protocol
for infants exposed to
opioids, and monitor
for S/S of withdrawal
24 hours after
discontinuing an
opioid. Have protocol
and screening in place
at nurseries for S/S of
NAS or risk of
developing
withdrawal.

Limitations of
Findings:
“Studies have not
addressed
whether longterm morbidity
related to neonatal
drug withdrawal
is decreased by
pharmacologic
management of
affected infants,
or whether
continued
postnatal drug
exposure
augments the risk
of
neurobehavioral
and other
morbidities. It is
possible that
pharmacologic
therapy of the
infant may
introduce or
reinforce a
maternal
disposition to rely
on drugs for the
treatment of
infant discomfort
or annoying
behavior” (p.
e548).
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13: Isemann, B.,
Meinzen-Derr, J.,
Akinbi, H. (2011).
Maternal and neonatal
factors impacting
response to methadone
therapy in infants
treated for neonatal
abstinence syndrome.
Journal of
Perinatology, 31, 25–
29.
doi:10.1038/jp.2010.6
6

Purpose Statement: To
coordinate a managed
care plan for opiate
dependent women that
reduces the public health
burden posed by NAS, by
outlining the risks of fetal
drug exposure,
emphasizes the benefits
of providing mother
breast milk to infants, and
cautions against rapidly
weaning infants from
mother breast milk.
Research Question: Is
there a reduced public
health burden posed by
NAS when opiate
dependent women are
treated through a
managed care plan?

Setting: In the newborn
intensive care unit at The
University Hospital in
Cincinnati, Ohio.
Sampling Method: All
newborns that received
methadone therapy for
NAS at The University
Hospital between January
2002 and December 2007.
Sample Size: 128 infants,
with a total of 1528
methadone treatment days
were included in the
analyses. Of the 128
infants, 56 of the term
infants had breast milk
available to them.

Design:
Retrospective
Cohort Study
Level of
Evidence: 4

14: Jansson, L. M.,

Purpose Statement: To

Setting: N/A

Design:
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later and less
frequently requires
pharmacologic
intervention” (p.
e548).
Findings: Shorter
median duration of
methadone therapy
in both preterm
and term infants
were found with
infants feed breast
milk. Breast milk
feed infants had a
shorter hospital
stay, 3 to 51 days,
compared to
formula fed infants
hospital stay
ranging from 9 to
43 days. Through
the study they
estimated that the
intake of
methadone from
breast milk could
be as high as
0.05mg kg daily,
which may help
prevent or decrease
the severity of
NAS.

Practice & Research
Implications:
Through the study,
they taught the women
not to abruptly stop
infant’s ingestion of
breast milk, for it
could precipitate
rebound withdrawal. I
would like to see more
future studies
identifying infants at
risk for rebound NAS.
The article states
providers should aim
for a individualized
approach to initial
methadone dosing,
which takes into
consideration the
gestational age and the
availability of breast
milk as a primary
nutrition. Due to this
finding, I think it is
important for more
physicians taught on
proper methadone
dosing.
“More infants in the While it appears that

Limitations of
Findings: The
retrospective
study had
incomplete data
collection from
the medical
records, and
stated that infants
rehospitalized for
withdrawal
symptoms may
have been
underestimated.
Also, since the
article was about
benefits of
breastfeeding to
help with NAS,
the article stated
they may have
possibly
contributed to
decreased length
of hospital stay
due to bias in
initiating therapy.

The study’s results
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Choo, R., Velez, M.
L., Harrow, C.,
Schroeder, J. R.,
Shakleya, D. M., &
Huestis, M. A. (2008).
Methadone
maintenance and
breastfeeding in the
neonatal period.
Pediatrics, 121(1),
106–114.
doi:10.1542/peds.2007
-1182

evaluate concentrations of
methadone in breast milk
as well as maternal and
infant plasma among
methadone-maintained
breastfeeding women
compared to formulafeeding women.
Research Question: Is
there a difference in
concentrations of
methadone in breast milk
as well as maternal and
infant plasma among
methadone-maintained
breastfeeding women
compared to formulafeeding women?

Sampling Method:
Subjects enrolled in a
substance abuse treatment
program for pregnant and
postpartum drugdependent women between
January 2001 and
September 2005. Subjects
were included in the study
if they met the following
criteria: “Single daily dose
of methadone, absence of
significant fetal or
maternal complications,
singleton pregnancies,
expressing a desire to
breastfeed at routine
obstetric care visits,
abstinence from licit/illicit
substance use after 32
weeks gestation, and
compliance with program
standards” (p. 107).
Sample Size: Eight
women met the criteria and
were called the
breastfeeding group. These
women were compared to
eight control subjects who
were called the formulafeeding group.

Controlled
Trial without
Randomizatio
n
Level of
Evidence: 3

15: Kocherlakota, P.
(2014). Neonatal
abstinence syndrome.

Purpose Statement:
To explain NAS, its
history, clinical

Setting: Children’s
Design:
Hospital at New York
Systematic
Medical College, Valhalla, Review
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control (formulafed) group required
pharmacologic
treatment for NAS
(4 infants,
compared with 1
breastfed infant),
but this association
was not statistically
significant” (p.
110). A substantial
increase in
methadone
concentrations in
breast milk was
noted over time.
“There was no
significant
correlation between
maternal methadone
doses and infant
plasma methadone
concentrations”
(p.112). There was
no association
between neonatal
methadone
concentrations and
breastfeeding or
receiving
pharmacologic
treatment for NAS.
Findings:
“Breastfeeding
may decrease the

the benefits of
breastfeeding outweigh
the effect a small
concentration of
methadone found in
breast milk might have,
more research should
be performed to
determine the longterm effects of
methadone on
developing infants.
Overall, the study
recommends
breastfeeding among
pregnant women
maintained on
methadone.

Practice & Research
Implications: Assess
neurological and

are based on very
small group sizes.
The results exhibit
bias due to the
need for
reconstitution of
several infant
plasma specimens
that dried out
while in storage.
This caused those
concentration
values to be
overestimated.

Limitations of
Findings:
Healthcare bias
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Pediatrics, 134(2),
e547–e561.
doi:10.1542/peds.2013
-3524

presentations, treatments,
and discharge/follow-up.
Research Question:
What is Neonatal
Abstinence Syndrome?

New York.
Sample Method:
Complication of multiple
journal articles.
Sample Size: 187 journal
articles.

16: Kraft, W. K.,
Gibson, E., Dysart, K.,
Damle, V. S.,
LaRusso, J. L.,
Greenspan, J. S., …
Ehrlich, M. E. (2008).
Sublingual
buprenorphine for
treatment of neonatal
abstinence syndrome:
a randomized trial.
Pediatrics, 122(3),
e601–e607.
https://doi.org/10.1542
/peds.2008-0571

Purpose Statement: To
determine the viability,
safety, and effectiveness
of treating neonates with
Neonatal Abstinence
Syndrome with
sublingual buprenorphine
compared to the standard
care neonatal opium
solution (NOS).
Research Question: Is
there a difference in
viability, safety, and
effectiveness of treating
neonates with Neonatal
Abstinence Syndrome

Setting: Thomas Jefferson
University Hospital in
Philadelphia.
Sampling Method:
Mothers in labor who were
admitted between April
2005 and January 2008
were included in the study
if they met the following
criteria: “>37 weeks’
gestation, exposure
to opioids in utero, and
demonstration of signs and
symptoms of NAS that
required treatment” (p.
e602). Mothers and their

Level of
Evidence: 1

Design:
Randomized
Controlled
Trial
Level of
Evidence: 2
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incidence of NAS,
the need for
pharmacological
treatment, and the
length of the
hospital stay” (p.
e555).
“Nonpharmacologi
cal therapy is the
first option in all
cases, and may
suffice in cases of
mild withdrawal.
Nonpharmacologic
al therapy is easily
acceptable, less
expensive, and less
controversial” (p.
e553).
Findings: The
average length of
treatment for
neonates treated
with
buprenorphine was
22 days compared
to 32 days for
neonates treated
with NOS. The
average length of
hospital stay was
27 days for
neonates treated
with
buprenorphine

motor function,
psycho-behavioral
behavior, growth and
nutrition for
abnormalities and
setbacks.

against mothers
who breastfeed
while on opioid
agonist treatment.
Mothers don’t
continue
breastfeeding
after they leave
the hospital.

Practice & Research
Implications:
Although the findings
of this study suggest
that buprenorphine is
viable, safe, and
effective treatment, a
double-blind clinical
trial with a larger
sample size should be
conducted in order for
findings to be found
statistically
significant.

Limitations of
Findings: This
study was a single
site pilot study,
which means that
findings cannot be
generalized to the
neonate
population as a
whole.
Additionally, bias
couldn’t be
completely
eliminated during
scoring of
symptom severity.
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with sublingual
buprenorphine compared
to neonatal opium
solution (NOS)?

17: Kraft, W. K.,
Adeniyi-Jones, S. C.,
Chervoneva, I.,
Greenspan, J. S.,
Abatemarco, D.,
Kaltenbach, K.,
Ehrlich, M. E. (2017).
Buprenorphine for the
treatment of the
neonatal abstinence
syndrome. New
England Journal of
Medicine 376(24),
2341-2348.
doi:10.1056/NEJMoa1
614835

Purpose Statement: “In
the single-site,
randomized, doubleblind, double-dummy
Blinded
Buprenorphine or
Neonatal Morphine
Solution
(BBORN) trial, we
compared sublingual
buprenorphine with oral
morphine with respect
to the duration of
treatment in infants with
the neonatal abstinence
syndrome” (p. 2342).
Research Question:
Which pharmacologic
treatment decreases the
duration of treatment in
infants with NAS,
buprenorphine or
morphine?

infants who qualified were
then randomly assigned to
receive either sublingual
buprenorphine or NOS.
Sample Size: 26 neonates
met the inclusion criteria.
13 neonates were treated
with buprenorphine and 13
were treated with NOS.
Setting: Thomas Jefferson
University Hospital in
Philadelphia
Sampling Method:
Mothers in this study were
enrolled in an outpatient
methadone treatment
program from October 31,
2011 and May 29, 2016.
30 infants were randomly
assigned to receive
buprenorphine, while 28
were randomly assigned to
receive morphine.
Sample Size: 63 infants
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compared to 38
days for neonates
treated with NOS.
Unfortunately,
neither of these
findings was
statistically
significant.
Design:
Randomized
Controlled
Trial
Level of
Evidence: 2

Findings:
Buprenorphine is
useful for
treatment of
neonatal
abstinence
syndrome due to
its large
therapeutic index
for respiratory
depression, along
with having a long
half-life. Primary
outcomes included
a decrease of
duration of
treatment with
buprenorphine,
with the mean
number of days 13
days decrease
compared to those
treated with
morphine. A
decrease LOS of a
mean of 12 days

Practice & Research
Implications: This
studies results shares
the benefits of
buprenorphine over
morphine drug,
showing the
buprenorphine is
beneficial to the
treatment of NAS.
With these results,
buprenorphine should
be used more often in
these cases, and more
research should be
involved in this topic.

Limitations of
Findings: Some
limitations of this
study include the
small sample size
and the single
center design. The
study also
excluded preterm
infants and those
with
benzodiazepine
exposure in utero,
causing the results
to be invalid to
this population.
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was found with
buprenorphine.
18: Liu, A., Juarez, J., Purpose Statement:
Setting: Two birthing
Design:
Findings:
Nair, A., & Nanan, R. “...to compare the impact units in Western Sydney
Retrospective “After adjusting
(2015). Feeding
of different feeding
from 2000 to 2006.
Cohort Study for confounders,
modalities and the
modalities on the onset of Sample Method:
Level of
there was no
onset of the neonatal
NAS” (p. 1).
Researchers looked at the Evidence: 4
significant effect of
abstinence syndrome. Research Question:
medical records of 194
the modality of
Frontiers in
What is the mechanism
cases and organized the
feeding on the
Pediatrics, 3(14), 1-4. behind the beneficial
infants within the first 2
rates of NAS
doi:10.3389/fped.2015 effect of breast milk?
days of life. One group
requiring treatment
.00014
was mainly breastfed while
(p = 0.11).
the other was mainly
Breastfeeding
formula fed.
significantly
Sample Size: “…194
delayed the onset
methadone-maintained
of NAS (p = 0.04).
mother/infant dyads” (p.
The act of
1).
breastfeeding in
the first 2 days of
life had no effect
on whether an
infant required
treatment for NAS
when compared to
those fed EBM or
formula” (p. 1).
19: McKnight, S.,
Purpose Statement: To Setting: Kingston General Design:
The need for
Coo, H., Davies, G.,
determine the impact of
Hospital in Ontario,
Retrospective pharmacologic
Holmes, B., Newman, rooming-in care for
Canada
cohort study treatment has a
A., Newton, L., &
infants at risk of NAS on Sampling Method: The
Level of
strong association
Dow, K. (2015).
the necessity for
study population was all
Evidence: 4 with the length of
Rooming-in for
pharmacologic treatment infants considered at risk
hospital stay.
infants at risk of
and length of hospital
of developing NAS. The
Rooming-in was
neonatal abstinence
stay.
population was split into
found to decrease
syndrome. American
Research Question: Is
two groups. The first group
the need for

Practice & Research
Implications:
Breastfed infants
reacted to NAS the
same as those who
were formula fed.
They encourage
breastfeeding unless
contraindicated in the
mother. Breastfeeding
isn’t negative
concerning NAS
treatment and has
other positive benefits.

Limitations of
Findings:
The small sample
size of the sample
groups made it
difficult to prove
the advantages of
breastfeeding for
infants with NAS.

Future studies should
examine the cost
differences between
rooming-in and
admission to the NICU.
More research should
be done to test the
relationship between
breastfeeding and

The study was
nonrandomized
and uncontrolled.
The study’s small
population
numbers could
have made it
difficult to
statistically detect
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Journal of
Perinatology, 33(5),
495-501.
doi:10.1055/s-00351566295

there a difference in the
need for pharmacologic
treatment and length of
hospitalization for infants
at risk of neonatal
abstinence syndrome
(NAS) who take part in a
rooming-in program
compared to those who
receive standard care?

of infants was born
between May 1, 2012 and
May 31, 2013 as these
infants were admitted to
the NICU. Infants born
between June and August
of 2013 were excluded.
The second group of
infants was born between
September 1, 2013 and
September 30, 2014 as
these infants roomed-in
with their mothers.
Sample Size: There were a
total of 44 infants with 24
in the NICU group and 20
in the rooming-in group.
20: Newman, A.,
Purpose Statement: “To Setting: Kingston General
Davies, G. A., Dow, implement a rooming-in
Hospital located in
K., Holmes, B.,
program to support close
Ontario. A tertiary care
Macdonald, J.,
uninterrupted contact
referral centre with a level
McKnight, S., &
between opioid-dependent 3 NICU.
Newton, L. (2015).
women and their infants in Sampling Method: All
Rooming-in care for order to decrease the
known opioid dependent
infants of opioidseverity of NAS scores,
mothers attending the
dependent mothers:
lessen the need for
multidisciplinary antenatal
Implementation and
pharmacotherapy, and
clinics by September 30th,
evaluation at a tertiary shorten hospital stays” (p. 2014. Exclusion criteria if
care hospital.
e555).
had planned apprehension
Canadian Family
Research Question: Is
by child protection
Physician, 61(12),
there a difference in
services or existence of
e555–e561. Retrieved severity of NAS scores,
another neonatal condition
from
the need for
that would require
http://web.a.ebscohost. pharmacotherapy, or
admission to the NICU.
com.ezproxy.uakron.e length of hospital stay
Sample Size: 21 women
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pharmacologic
treatment, decrease
length of hospital
stay, and is
independent of
breastfeeding.

Design:
Controlled
Trials without
Randomizatio
n
Level of
Evidence: 3

Findings: The
neonates in the
rooming in cohort
had significantly
lower oral
morphine therapy
(14.3%) compared
to those admitted
directly to the
NICU (83.3%).
The LOS for those
rooming in was 7.9
days, compared to
24.8 days seen in
those directly
admitted to the
NICU.

rooming-in. Futures
research should
evaluate the possible
barriers to employing
rooming-in for
pregnant substance
users and their
neonates.

Practice & Research
Implications: Due to
the significant
findings in this
research article, it is
important for more
hospitals to implement
neonates rooming in
rather than admitting
them to the NICU.

differences
between the two
groups that could
have affected the
study’s results.
The study did not
compare the types
of drugs used by
the mothers in the
two groups.

Limitations of
Findings: There
might be a
possible source of
bias regarding the
NAS scoring tool,
for to quantify
withdrawal
severity,
subjective
judgment is used
to some degree.
Future research
also has to be
done to look at
neonatal and
childhood
outcomes in the
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du

21: O’Connor, A. B.,
Collett, A., Alto, W.
A., & O’Brien, L. M.
(2013). Breastfeeding
rates and the
relationship between
breastfeeding and
neonatal abstinence
syndrome in women
maintained on
buprenorphine during
pregnancy. Journal of
Midwifery & Women’s
Health, 58(4), 383–
388.
doi:10.1111/jmwh.120
09

with opioid dependent
mothers and their neonates
cared for with the new
rooming in program,
compared to those not
rooming in?
Purpose Statement: To
examine breastfeeding
rates among opioiddependent pregnant
women on buprenorphine
maintenance treatment
and to determine the
effects of breastfeeding
on length, intensity, and
frequency of
pharmacologic treatment
for neonates with NAS.
Research Question: Is
there a difference in
length, intensity, and
frequency of
pharmacologic treatment
for neonates with NAS
who receive breast milk
compared to nonbreastfed neonates?

were admitted to a private
room in the pediatrics unit
with their full term infants.
24 women whose babies
were directly admitted to
the NICU for direct
observation.
Setting: “An integrated
medical and behavioral
health program for opioiddependent women…” (p.
384).
Sampling Method: The
charts of all opioiddependent pregnant
women on buprenorphine
maintenance treatment
who were in the integrated
program from December
2007 to August 2012 were
reviewed.
Sample Size: 85 motherinfant pairs were examined
in this study.
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long run.

Design:
Retrospective
cohort study
Level of
Evidence: 4

“Although not
statistically
significant,
preliminary results
suggest that
breastfeeding may
attenuate NAS” (p.
385). The average
NAS score and
likelihood of
pharmacologic
treatment were
lower in breastfed
neonates. NAS
symptoms resolved
approximately 2
hours earlier in
breastfed neonates
than in nonbreastfed neonates.

Although initial
findings are positive,
more research should
be done with larger
sample sizes to
determine if
breastfeeding causes a
statistically significant
difference in NAS
severity and need for
pharmacologic
treatment.

This study could
not measure the
effects of
breastfeeding on
length of hospital
stay because other
variables (such as
pregnancy
complications
other than NAS)
were present in the
study’s sample.
Because this study
is nonrandomized
and uncontrolled,
it cannot be used
to determine cause
and effect. There
was information
missing regarding
why the women in
this study chose to
begin and/or stop
breastfeeding.
Additionally, it is
hard to
differentiate the
positive effects of
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breastfeeding from
other
nonpharmacologic
treatments, such as
skin-to-skin
contact that occurs
during
breastfeeding. The
small sample size,
especially
regarding the
number of
neonates in the
non-breastfed
group, diminished
the study’s ability
to show statistical
significance.
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22: Ordean, A.,
Kahan, M., Graves, L.,
Abrahams, R., & Kim,
T. (2015). Obstetrical
and neonatal outcomes
of methadonemaintained pregnant
women: A canadian
multisite cohort study.
Journal of Obstetrics
and Gynaecology
Canada, 37(3), 252–
257.
doi:10.1016/S17012163(15)30311-X

Purpose Statement: To
compare obstetrical and
neonatal outcomes,
including NAS, among
methadone-maintained
pregnant women across
three Canadian
metropolitan cities.
Research Question: Is
there a difference in
obstetrical and neonatal
outcomes, including
NAS, among methadonemaintained pregnant
women across three
Canadian metropolitan
cities?

23: Pritham, U. A.
(2013). Breastfeeding
promotion for
management of
neonatal abstinence
syndrome. Journal of
Obstetric, Gynecologic

Purpose Statement:
“...to educate perinatal
clinicians and substance
abuse treatment
specialists about NAS
and the interplay of
breastfeeding, skin-to-

Setting: The Sheway
Clinic in Vancouver
(which uses rooming-in
care for infants with NAS),
the Toronto Centre for
Substance Use in
Pregnancy, and the Herzl
Family Practice Centre in
Montreal (both of which
admit infants with NAS to
the NICU).
Sampling Method:
Reviewed the medical
records of pregnant women
with a history of opioid use
that were eligible for or
already receiving
methadone-maintenance
treatment (MMT) at
integrated care programs in
three Canadian cities from
1997 to 2009.
Sample Size: There were a
total of 94 women in the
study with 36 from
Toronto, 36 from
Vancouver, and 22 from
Montreal.
Setting: PubMed,
CINAHL, and Medline
Sample Method: In the
databases mentioned above,
the keywords used were:
“…opioid dependency in
pregnancy, neonatal

Design:
Retrospective
cohort study
Level of
Evidence: 4

Design:
Systematic
Review
Level of
Evidence: 1
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In the Vancouver
site where roomingin care was used,
there was a reduced
rate of NICU
admission, an
increased length of
hospital stay, and a
shorter duration of
NAS treatment.
These findings are
all consistent with
the hypothesis that
rooming-in
decreases the need
for treatment of
newborns with
NAS.

Findings:
Breastfeeding is
shown to decrease
need of treatment,
LOS, severity, and
duration of NAS.
It is also shown to

Policies should
promote maternalnewborn contact,
rooming-in care, and
breastfeeding as
methods to decrease
NAS symptoms and
the need for
pharmacologic
treatment.

This study is
nonrandomized
and uncontrolled.
There are
inconsistencies
and omissions in
the data due to
frequent
documentation
issues in patient
charts.
Additionally, the
results of this
study may not be
universally
applicable to
methadonemaintained
pregnant women
who have not
received prenatal
care.

Practice & Research
Implications: This
study encourages
healthcare workers to
reassure and educate
the mothers of opioiddependent infants about

Limitations of
Findings:
“Further research
is needed to
determine
differences in
NAS between
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& Neonatal Nursing,
42(5), 517–526.
doi:10.1111/15526909.12242

skin contact, and
swaddling on NAS
symptom management”
(p. 517).
Research Question:
Should breastfeeding be
recommended as a longterm health treatment for
high risk mothers and
their newborn infants
with NAS?

abstinence syndrome,
methadone, buprenorphine,
neonatal length of stay,
breastfeeding, methadone in
breast milk, buprenorphine
in breast milk, swaddling,
and rooming-in” (p. 517).
Sample Size: Articles
published between January
1990 and April 2013.

24: Raffaeli, G.,
Cavallaro, G.,
Allegaert, K.,
Wildschut, E. D.,
Fumagalli, M., Agosti,
M., Tibboel, D.,
Mosca, F. (2017).
Neonatal abstinence
syndrome: Update on
diagnostic and
therapeutic strategies.
Pharmacotherapy
Publications 37(7),
814-823.
doi:10.1002/phar.1954

Purpose Statement:
“The aim of this review
is to examine recent
and relevant scientific
literature on NAS, to
increase awareness of the
severe potential impact
of in utero drug exposure
on the developing
child, and to highlight
preventive strategies,
early diagnosis,
educational programs,
evidence based
standardized
management, and
research
agendas as priority

Setting: Medical journals.
Sampling Method:
Reviewing recent and
relevant scientific literature
on NAS.
Sample Size: N/A
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promote bonding
and infant
attachment
between the
mother and child.

Design:
Expert
Opinion
Level of
Evidence: 7

the benefits of
neonates who
breastfeeding, both for were breastfed
the mother and infant. and those who
were fed pumped
breast milk or
donor milk. The
safety of
breastfeeding
while on
psychotropic
medications with
opioid
replacement
therapy also needs
further
exploration” (p.
524).
Findings:
Practice & Research Limitations of
Morphine is often Implications: More
Findings:
the first line agent tailored therapy
Limitations of
to treat NAS with regarding
this study involve
methadone being
pharmacologic
no specifically
another alternative, management should be stating how many
but its safety
done to better
articles were
profile is not
understand the risks
reviewed, where
totally known. 50- associated with them. they were found,
80% of opiate
Community awareness and the time
exposed neonates of the impact of NAS period these
require
on health care will
articles were
pharmacologic
maybe generate
published.
management.
supportive policies to
Compared with
expand on research
methadone,
related to this topic.
buprenorphineImplementation of
exposed neonates standard weaning
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issues” (p. 815).
Research Question:
What does recent and
relevant scientific
literature have to say
regarding NAS, and
evidence based
standardized
management?
25: Saiki, T., Lee, S., Purpose Statement: To
Hannam, S., &
determine if caring for
Greenough, A. (2010). infants with NAS on the
Neonatal abstinence
postpartum unit with
syndrome—postnatal their mothers will reduce
ward versus neonatal
treatment duration and
unit management.
length of hospital stay
European Journal of
when compared to infants
Pediatrics, 169(1), 95. admitted to the NICU or
doi:10.1007/s00431neonatal unit.
009-0994-0
Research Question: Is
there a difference in
treatment duration and
length of hospital stay in
infants with NAS when
they are cared for on the
postpartum unit
compared to in the NICU
or neonatal unit?

26: Welle-Strand, G.
K., Skurtveit, S.,
Jansson, L. M.,

Setting: King’s College
Hospital (KCH) in
Denmark Hill, London,
UK
Sampling Method: Two
groups of infants with NAS
were examined. The first
group was comprised of all
infants with NAS cared for
between 2002 and 2005
who were admitted to the
neonatal unit. The second
group was comprised of all
infants with NAS cared for
between 2006 and 2007
who remained on the
postpartum unit with their
mother.
Sample Size: There were
42 infants in the neonatal
unit group and 18 infants
in the postpartum unit
group.
Purpose Statement: “To Setting: Regional
examine the rate and
treatment centres for OMT
duration of breastfeeding in Norway, 18 different
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have a milder NAS protocols is also
course.
important to research
more on, for it has a
positive impact on
length of
pharmacologic
therapy.

Design:
Retrospective
cohort study
Level of
Evidence: 4

Design:
Retrospective
Cohort Study

Infants who were
cared for on the
postpartum unit
with their mother
required less
treatment, a
decreased length of
treatment, and a
decreased length of
hospital stay.

Findings: 77
percent of the
women in OMT

Further studies,
particularly
randomized trials,
should be performed to
examine postpartum
unit management of
infants with NAS.

The largest
limitation to this
study was that it
was not a
randomized trial.

Practice & Research Limitations of
Implications: Since
Findings: Only
breastfeeding benefits one part of the
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Bakstad, B., Bjarkø,
L., & Ravndal, E.
(2013). Breastfeeding
reduces the need for
withdrawal treatment
in opioid exposed
infants. Acta
Paediatrica, 102(11),
1060-1066.
doi:10.1111/APA.123
78

in a cohort of women in
opioid maintenance
treatment (OMT) in
Norwary, as well as the
effect of breastfeeding on
the incidence and
duration of NAS” (p.
1060).
Research Question: Is
there a difference in the
duration or incidence of
NAS as a result of
breastfeeding in a cohort
of women in OMT?

hospitals were used.
Level of
Sampling Method: “A
Evidence: 4
national cohort of women
treated with either
methadone or
buprenorphine during
pregnancy, and their
neonates born between
1999 and 2009” (p. 1060).
A standard questionnaire
was passed out and
medical information was
collected to confirm selfreported data.
Sample Size: A total of
124 women and children
were included in this study.

56

breastfed.
Breastfed neonates
who prenatally
were exposed to
methadone
required less
pharmacotherapy
for NAS. All
breastfed neonates
needed less
pharmacological
treatment for NAS
compared to those
who were not
breastfed.

both the mother and
child, we need to
increase the rates
among women in
OMT. We need to
increase support for
these women. It may
already be harder for
them due to lactation
difficulty found in
OMT women and Nas
associated behaviours
make breastfeeding
more difficult.

study consisted of
a prospective
design, and the
retrospectively
designed study
maybe have less
accurate data due
to relying on
recall. Also, the
children were
born in 18
different hospitals
with different
assessment skills
of NAS at each.
Lastly, the
questionnaire did
not cover
breastfeeding that
in depth, so we
don’t know how
long the women
exclusively
breastfed for.

